A new UK clinical trial has found that a wearable mini-pump can safely help heart failure patients continue treatment at home ...
SQ Innovation’s topline data evaluating its Lasix Onyu home care oedema treatment versus SoC IV was shared at the 2026 Heart Failure Congress in Barcelona.
A wearable mini-pump device that allows heart-failure patients to receive medication at home rather than in hospital has been ...
This week, the FDA granted clearance to Withings’ BPM Pro 2 cellular blood pressure monitor. The device seeks to help providers scale remote patient monitoring for heart failure patients. Bayer ...
CVRx’s stock has risen nearly 20% after the company revealed that its heart failure device is set to be investigated in an expanded patient population. In the BENEFIT-HF clinical trial (NCT07232030), ...
A simple, lightweight device worn on the sternum can calculate intracardiac filling pressures, warning that heart failure is worsening, according to a study conducted to determine whether the device ...
Institutional investors in the United States have committed to buy $3.5 million-worth of Sunshine Heart Inc. (ASX: SHC) shares in a private placement — that is, if the company’s Australian ...
MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results